Correlation Between Microbial Infection and Lumbar Degenerative Disease Based on High-throughput Gene Sequencing
NCT ID: NCT06075979
Last Updated: 2025-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2020-01-02
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multivariate Analysis and Risk Factors Were Used to Predict the Short-term Postoperative Pain of Degenerative Lumbar Spine
NCT06628583
The Study of INTRA Spine Non Fusion Technique in the Treatment of Lumbar Degenerative Disease
NCT06075966
The Role of Cutibacterium Acnes in the Development of Degenerative Lumbar Intervertebral Disc Disease
NCT07085247
Study to Evaluate Safety and Effectiveness of Dynamic Stabilization Versus Lumbar Fusion in Treatment of Multilevel Lumbar Disc Degeneration Disease
NCT02385695
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration
NCT01643681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lumbar disc herniation group
Patients undergoing surgery for lumbar disc herniation
Lumbar disc herniation
Patients undergoing surgery for lumbar disc herniation
Lumbar spinal stenosis
Patients undergoing surgery for lumbar spinal stenosis
Lumbar spinal stenosis group
Patients undergoing surgery for lumbar spinal stenosis
Lumbar disc herniation
Patients undergoing surgery for lumbar disc herniation
Lumbar spinal stenosis
Patients undergoing surgery for lumbar spinal stenosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lumbar disc herniation
Patients undergoing surgery for lumbar disc herniation
Lumbar spinal stenosis
Patients undergoing surgery for lumbar spinal stenosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who undergo strict conservative treatment for 3 months before surgery have no significant improvement in symptoms; The control group of patients had no significant lumbar disc degeneration evaluated by imaging, but needed surgical decompression and fusion intervention due to trauma causing lumbar fractures, lumbar tumors, scoliosis.
* The disc organizer can be obtained during surgery.
Exclusion Criteria
* Lumbar degenerative diseases combined with mental diseases.
* Lumbar degenerative diseases combined with metal allergy.
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaoxuanZhang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HaoxuanZhang
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hao-Xuan Zhang, Ph.D/MD
Role: STUDY_CHAIR
Shandong First Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hao-Xuan Zhang
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
High-throughput gene
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.